First Trimester Prediction of Uteroplacental Disease- Results of the Prospective Handle Study

Kathy Monteith

Research output: Contribution to journalArticlepeer-review

Abstract

To assess the ability of non-invasive cardiac output monitoring (NICOM), a novel method of non-invasive maternal hemodynamic assessment using bioreactance, in combination with first trimester biomarkers to predict the evolution of gestational hypertension (GH), pre-eclampsia (PE) and normotensive fetal growth restriction (FGR).
Original languageEnglish
Pages (from-to)S207-S207
JournalAmerican Journal of Obstetrics and Gynecology
Volume218
Issue number1
DOIs
Publication statusPublished - 1 Jan 2018
Externally publishedYes

Keywords

  • non-invasive cardiac output monitoring
  • NICOM
  • non-invasive maternal hemodynamic assessment
  • bioreactance
  • first trimester biomarkers
  • gestational hypertension
  • GH
  • pre-eclampsia
  • PE
  • normotensive fetal growth restriction
  • FGR

Fingerprint

Dive into the research topics of 'First Trimester Prediction of Uteroplacental Disease- Results of the Prospective Handle Study'. Together they form a unique fingerprint.

Cite this